RecruitingNot ApplicableNCT05976165
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
Breath Testing for Small Intestinal Bacterial Overgrowth in Patients Treated With Proton Pump Inhibitors
Sponsor
Mayo Clinic
Enrollment
50 participants
Start Date
Nov 17, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Predominant symptoms of gastroesophageal reflux disease including heartburn, regurgitation
- Subjects must be able to give appropriate informed consent
Exclusion Criteria9
- Prior diagnosis of SIBO
- Use of PPIs or H2R-anatagonstists in the prior 3 months
- Major concomitant illness (renal, hepatic, rheumatologic or cardiovascular disease, or malignancy)
- Antibiotic therapy within one month
- Prior gastrointestinal surgery including esophageal, gastric, and small or large bowel surgery
- Previously diagnosed irritable bowel syndrome or inflammatory bowel disease
- Individuals who are pregnant or breast feeding
- Patients with plans to become pregnant
- Inability to take PPIs, including allergy/sensitivity
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBreath Testing
Subjects drink a small carbohydrate solution, and then provide a breath sample every 15 minutes for one hour, and then every 30 minutes for the next two hours
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05976165
Related Trials
Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
NCT072917002 locations
Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
NCT075063561 location
Compassionate Use of Domperidone for Refractory Gastroparesis
NCT046995911 location
External UES Band (Shaker Pressure Band) and GERD
NCT056973931 location
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
NCT044118232 locations